Skip to main content
Arie Perry on Muck Rack

Arie Perry

As seen in: Color Research & Application, Nature, JAMA Oncology, Cell Press, The Lancet, Archives of Pathology
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Arie

Contact Arie, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Distinct molecular subgroups in pediatric and young-onset meningiomas require age-adapted risk stratification

|
By Arnault Tauziède-Espariat, Thomas Hielscher, Daniel Schrimpf, Kirsten Göbel, Eric Y. Stutheit-Zhao, Lukas Friedrich, Felix Keller, Fuat Kaan Aras, Filippo Nozzoli, Dominik Sturm, Christine White, Simone Schmid, Christian Mawrin, Julia E. Neumann, Rudi Beschorner, Christian Hartmann, Mariette Kranendonk, Sybren L. N. Maas, Eelke M Bos, Eleonora Aronica, Saskia M Peerdeman, Nikki B. Thuijs, Angelika Mühlebner, Benno Kusters, Cinzia E. Lavarino, Stéphanie Puget, Jason Chiang, Sonika Dahiya, Melike Pekmezci, Arie Perry, Miriam Ratliff, Christel Herold-Mende, Sandro M. Krieg, Wolfgang Wick, Stefan M. Pfister, Pieter Wesseling, Andreas von Deimling, Pascale Varlet, Felix Sahm, Philipp Sievers, Natalie Berghaus, Dilan Savran, Irem Saribiyik, Arda Inan, Ayça Erşen-Danyeli, Wilfred F. A. den Dunnen, Oluwadamilola Akanji
| Nature Verified
Abstract Meningiomas in pediatric and adolescent/young adult patients are poorly characterized biologically and clinically, and risk stratification is largely extrapolated from adult tumors. We analyze 293 tumors from patients aged 0–39 years using integrated histopathological and molecular profiling.
Open in Who Shared Issue with article?

Prospective Genomic Profiling of Consecutive Meningiomas

|
By MINH NGUYEN, Minh Nguyễn, Kanish Mirchia, Brooke C. Braman, Ramin A. Morshed, Zora Arum, Javier Villanueva-Meyer, William Chen, Jessica van Ziffle, Aleksandar Rajkovic, Susan M Chang, Walter Patrick Devine, Arie Perry, David R. Raleigh, Nancy Ann Oberheim-Bush
| JAMA Oncology Verified
Meningioma molecular profiling has revealed biological drivers and therapeutic vulnerabilities,1 but existing studies have used retrospective nonconsecutive samples, which provide suboptimal approximations of molecular alteration prevalence across demographic groups. Herein, we report findings from prospective genomic profiling of 1104 consecutive meningiomas.
Open in Who Shared Issue with article?

Advancing CNS tumor diagnostics with expanded DNA methylation-based classification

|
By Martin Sill, Daniel Schrimpf, Areeba Patel, Dominik Sturm, Natalie Jäger, Philipp Sievers, Leonille Schweizer, Rouzbeh Banan, David E. Reuss, Abigail K. Suwala, Andrey Korshunov, Damian Stichel, Annika K Wefers, Ann-Christin Hau, Henning Boldt, Patrick N. Harter, Zied Abdullaev, Jamal Benhamida, Daniel Teichmann, Arend Koch, Jürgen Hench, Stephan Frank, Martin Hasselblatt, Sheila Mansouri, Jonathan Serrano, Jonas Ecker, Michael Taylor Verified, Vijay Ramaswamy, Anna S. Berghoff, Brigitte Bison, Mirjam Blattner-Johnson, Ivo Buchhalter, Gabriele Calaminus, Nicola Dikow, Hildegard Dohmen, Philipp Euskirchen, Gudrun Fleischhack, Amar Gajjar, Nicolas U. Gerber, Marco Gessi, Gerrit H. Gielen, Astrid K. Gnekow, Nicholas G Gottardo, Christine Haberler, Stefan Hamelmann, Jordan Hansford, Christian Hartmann, Frank L. Heppner, Pablo Hernáiz Driever, Katja von Hoff, Ulrich W. Thomale, Michael C. Frühwald, Christof M. Kramm, Ulrich Schüller, Jens Schittenhelm, Martin Schuhmann, Marco Stein, Petra Ketteler, Marc Ladanyi, Nada Jabado, Barbara Jones, Chris Jones, Matthias A. Karajannis, Uwe Kordes, Annekathrin Reinhardt, Christian Kölsche, Katrin Lamszus, Peter Lichter, Sybren L.N. Maas, Christian Mawrin, Michel Mittelbronn, Camelia-Maria Monoranu, Wolf Mueller, Martin Mynarek, Paul A. Northcott, Kristian W. Pajtler, Werner Paulus, Arie Perry, Ingmar Blümcke, Karl H. Plate, Michael Platten, Matthias Preusser, Torsten Pietsch, Marco Prinz, Guido Reifenberger, Bjarne W. Kristensen, Marcel Kool, Volker Hovestadt, David Ellison, Thomas Jacques, Pascale Varlet, Nima Etminan, Michael Weller, Christine White, Olaf Witt, Christel Herold-Mende, Jürgen Debus, Sandro M. Krieg, Wolfgang Wick, Matija Snuderl, Sebastian Brandner, Cynthia Hawkins, Craig M Horbinski, Christian Thomas, Pieter Wesseling, Andreas von Deimling, David Capper, Stefan M. Pfister, Felix Sahm, Florian Selt, Rolf Buslei, Volkmar Hans, Stephan Tippelt, Ralf Ketter, Patricia Kohlhof, Ken Aldape
| Cell Press Verified
ArticleOnline nowOpen access 1Hopp Children’s Cancer Center Heidelberg (KiTZ), Heidelberg, Germany 2Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany 3Department of Neuropathology, University Hospital Heidelberg, Heidelberg, Germany 4Clinical Cooperation Unit Neuropathology, German Consortium for Translational Cancer Research (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany 5Division of Pediatric...
Open in Who Shared Issue with article?
See all 14 licensed articles (15 Total)